Tags: Clinical Trials

announcements

Three New Grants Keep Promising Programs Forging Ahead

The Alzheimer’s Drug Discovery Foundation (ADDF) announces three new investments, all of which are for programs that the ADDF previously funded.

announcements

New Report Highlights Innovation in Alzheimer’s Clinical Trials

Closing in on a Cure: 2017 Alzheimer’s Clinical Trials Report surveys the 126 drugs in clinical development for Alzheimer’s disease—20% of which received support from the Alzheimer’s Drug Discovery Foundation. 

blog

CTAD Conference Highlights Our Funded Research

This Wednesday marks the beginning of National Alzheimer's Disease Awareness Month and the 10th Clinical Trials on Alzheimer's Disease conference, which features a record amount of research we have supported.

announcements

Dr. Roberta Diaz Brinton Wins Alzheimer's Drug Discovery Foundation's Melvin R. Goodes Prize

Dr. Brinton has pioneered a promising neurogenesis therapy for Alzheimer’s disease.

announcements

18th Annual Conference on Alzheimer's Drug Discovery Showcases Non-Amyloid Research

Nearly 200 academic and industry researchers came together to share updates on innovative preclinical and clinical-stage Alzheimer’s disease research at the 18th Annual Conference on Alzheimer's Drug Discovery.

blog

Driving Innovation in Alzheimer's Therapies

At our 18th Annual Conference on Alzheimer’s Drug Discovery in Jersey City, the impact of our approach will take center stage.

blog

Inflammation, The Driver of Alzheimer's Disease?

A growing body of evidence suggests that inflammation in the brain is implicated in the development of Alzheimer's.

announcements

Latest Funding Includes Support for Innovative Clinical Trial

The ADDF announces four new grants, including support for an innovative clinical trial, two novel drug programs, and a biomarker for CTE.

announcements

2016 Annual Report Released

The 2016 Annual Report, titled “From Idea to Impact,” highlights the enormous progress the ADDF has made toward finding effective treatments for Alzheimer’s disease.

blog

Clinical Trials Inspiring Hope

Since 1998, the ADDF has invested over $100 million in the best ideas to cure Alzheimer's. We are seeing the impact of our efforts, with many promising drugs in clinical trials on the way.